내용 바로 가기

외상 및 응급의학과

초기 빈혈 관리

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (새로운 창 열기)

Ball AM, Winstead PS.

Source‎: Pharmacotherapy 2008;28(11):1383-90.

Indexed‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (새로운 창 열기)

Thalidomide for recurrent bleeding due to small-intestinal angiodysplasia. (새로운 창 열기)

Chen H, Wu S, Tang M, Zhao R, Zhang Q, Dai Z, Gao Y, Yang S, Li Z, Du Y, Yang A, Zhong L, Lu L, Xu L, Shen X, Liu S, Zhong J, Li X, Lu H, Xiong H, Shen Y, Chen H, Gong S, Xue H, Ge Z

Source‎: N Engl J Med. 2023 2;389(18):1649-59.

Indexed‎: PubMed 37913505

DOI‎: 10.1056/NEJMoa2303706

https://pubmed.ncbi.nlm.nih.gov/37913505/ (새로운 창 열기)

Bloodless management of the anemic patient in the emergency department. (새로운 창 열기)

Johnson-Arbor K, Verstraete R

Source‎: Ann Emerg Med 2022;79(1):48-57.

Indexed‎: PubMed 34353645

DOI‎: 10.1016/j.annemergmed.2021.06.015

https://pubmed.ncbi.nlm.nih.gov/34353645/ (새로운 창 열기)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (새로운 창 열기)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Source‎: J Trauma 2008;65(2):285-97.

Indexed‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (새로운 창 열기)

Erythropoiesis in multiply injured patients. (새로운 창 열기)

Robinson Y, Hostmann A, Matenov A, Ertel W, Oberholzer A.

Source‎: J Trauma 2006;61(5):1285-91.

Indexed‎: PubMed 17099548

DOI‎: 10.1097/01.ta.0000240969.13891.9b

https://www.ncbi.nlm.nih.gov/pubmed/17099548 (새로운 창 열기)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (새로운 창 열기)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Source‎: Arch Surg 2012;147(3):251-5.

Indexed‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (새로운 창 열기)